In fact, autocrine VEGF/VEGFR1 signaling, associated with increased tumor growth and tumor vascularity, may possibly confer the capacity to develop vasculogenic properties to OSA cells (66). This evidence concerns the gene FLT1 and obstructive sleep apnea syndrome.